BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37625896)

  • 1. FDA-cleared artificial intelligence and machine learning-based medical devices and their 510(k) predicate networks.
    Muehlematter UJ; Bluethgen C; Vokinger KN
    Lancet Digit Health; 2023 Sep; 5(9):e618-e626. PubMed ID: 37625896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance.
    Everhart AO; Sen S; Stern AD; Zhu Y; Karaca-Mandic P
    JAMA; 2023 Jan; 329(2):144-156. PubMed ID: 36625811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use.
    Zhu S; Gilbert M; Chetty I; Siddiqui F
    Int J Med Inform; 2022 Sep; 165():104828. PubMed ID: 35780651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the genealogy of medical device predicates in the United States.
    Pai DB
    PLoS One; 2021; 16(10):e0258153. PubMed ID: 34618861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis.
    Muehlematter UJ; Daniore P; Vokinger KN
    Lancet Digit Health; 2021 Mar; 3(3):e195-e203. PubMed ID: 33478929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulatory environment for artificial intelligence-enabled devices in the United States.
    Liang NL; Chung TK; Vorp DA
    Semin Vasc Surg; 2023 Sep; 36(3):435-439. PubMed ID: 37863617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices: A Systematic Review.
    Clark P; Kim J; Aphinyanaphongs Y
    JAMA Netw Open; 2023 Jul; 6(7):e2321792. PubMed ID: 37405771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Complex Process of Using the Interconnected Knee Arthroplasty Device Clearance Pathway.
    Zhu A; Ying X; Pean CA; Sheth NP; Cross MB; Gonzalez Della Valle A; Premkumar A
    HSS J; 2022 Nov; 18(4):462-468. PubMed ID: 36258781
    [No Abstract]   [Full Text] [Related]  

  • 9. Trends in clinical validation and usage of US Food and Drug Administration-cleared artificial intelligence algorithms for medical imaging.
    Khunte M; Chae A; Wang R; Jain R; Sun Y; Sollee JR; Jiao Z; Bai HX
    Clin Radiol; 2023 Feb; 78(2):123-129. PubMed ID: 36625218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mature artificial intelligence- and machine learning-enabled medical tools impacting vascular surgical care: A scoping review of late-stage, US Food and Drug Administration-approved or cleared technologies relevant to vascular surgeons.
    Stonko DP; Hicks CW
    Semin Vasc Surg; 2023 Sep; 36(3):460-470. PubMed ID: 37863621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shoulder arthroplasty device clearance: an ancestral network analysis.
    Zhu A; Ying X; Carey EG; Pean CA; Premkumar A; Fu MC; Taylor SA
    J Shoulder Elbow Surg; 2023 Mar; 32(3):671-676. PubMed ID: 36279987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Need for Medical Artificial Intelligence That Incorporates Prior Images.
    Acosta JN; Falcone GJ; Rajpurkar P
    Radiology; 2022 Aug; 304(2):283-288. PubMed ID: 35438563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulatory ancestral network of surgical meshes.
    Zargar N; Carr A
    PLoS One; 2018; 13(6):e0197883. PubMed ID: 29920525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Recalled Devices in New Device Authorizations Under the US Food and Drug Administration's 510(k) Pathway and Risk of Subsequent Recalls.
    Kadakia KT; Dhruva SS; Caraballo C; Ross JS; Krumholz HM
    JAMA; 2023 Jan; 329(2):136-143. PubMed ID: 36625810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatologic Device Clearance Within the Food and Drug Administration's 510(k) Pathway.
    Ezaldein HH; Hill ST; Merati M; Suggs A; Reichert B; Scott JF
    Lasers Surg Med; 2020 Nov; 52(9):837-841. PubMed ID: 32221981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA Review of Radiologic AI Algorithms: Process and Challenges.
    Zhang K; Khosravi B; Vahdati S; Erickson BJ
    Radiology; 2024 Jan; 310(1):e230242. PubMed ID: 38165243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial Intelligence in Breast Cancer Screening: Evaluation of FDA Device Regulation and Future Recommendations.
    Potnis KC; Ross JS; Aneja S; Gross CP; Richman IB
    JAMA Intern Med; 2022 Dec; 182(12):1306-1312. PubMed ID: 36342705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical device recalls and the FDA approval process.
    Zuckerman DM; Brown P; Nissen SE
    Arch Intern Med; 2011 Jun; 171(11):1006-11. PubMed ID: 21321283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database.
    Benjamens S; Dhunnoo P; Meskó B
    NPJ Digit Med; 2020; 3():118. PubMed ID: 32984550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How the FDA Regulates AI.
    Harvey HB; Gowda V
    Acad Radiol; 2020 Jan; 27(1):58-61. PubMed ID: 31818387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.